AC Immune (ACIU) Revenue (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 237.90% |
| Dec 31, 2025 | -63.97% |
| Sep 30, 2025 | -25.59% |
| Jun 30, 2025 | 43.26% |
| Mar 31, 2025 | -15.16% |
| Dec 31, 2024 | -95.59% |
| Sep 30, 2024 | 3,772.02% |
| Dec 31, 2020 | -14.41% |
| Sep 30, 2020 | 8.54% |
| Jun 30, 2020 | -91.15% |
| Mar 31, 2020 | 1,361.18% |
| Dec 31, 2019 | -61.09% |
| Sep 30, 2019 | 48.17% |
| Jun 30, 2019 | -98.00% |
| Mar 31, 2019 | 6,589.06% |
| Dec 31, 2018 | -51.92% |
| Sep 30, 2018 | 13.71% |
| Jun 30, 2018 | 34.02% |
| Mar 31, 2018 | -89.17% |
| Dec 31, 2017 | 1,265.35% |
| Sep 30, 2017 | 27.99% |
| Jun 30, 2017 | -59.36% |
| Mar 31, 2017 | 31.96% |
| Dec 31, 2016 | 13.61% |
| Sep 30, 2016 | -90.76% |
| Jun 30, 2016 | 2,842.46% |
| Mar 31, 2016 | -26.92% |
| Dec 31, 2015 | -97.35% |